iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.180
-0.030 (-2.48%)
Oct 27, 2025, 11:13 AM EDT - Market open

iBio, Inc. Statistics

Total Valuation

iBio, Inc. has a market cap or net worth of $23.90 million. The enterprise value is $19.50 million.

Market Cap23.90M
Enterprise Value 19.50M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date Nov 11, 2025
Ex-Dividend Date n/a

Share Statistics

iBio, Inc. has 20.25 million shares outstanding. The number of shares has increased by 174.05% in one year.

Current Share Class 20.25M
Shares Outstanding 20.25M
Shares Change (YoY) +174.05%
Shares Change (QoQ) +45.91%
Owned by Insiders (%) 3.95%
Owned by Institutions (%) 16.47%
Float 19.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 31.76
Forward PS n/a
PB Ratio 1.57
P/TBV Ratio 3.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 48.75
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.24.

Current Ratio 1.59
Quick Ratio 1.42
Debt / Equity 0.24
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -87.75

Financial Efficiency

Return on equity (ROE) is -101.52% and return on invested capital (ROIC) is -52.14%.

Return on Equity (ROE) -101.52%
Return on Assets (ROA) -44.79%
Return on Invested Capital (ROIC) -52.14%
Return on Capital Employed (ROCE) -108.92%
Revenue Per Employee $20,000
Profits Per Employee -$918,850
Employee Count20
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -59.30% in the last 52 weeks. The beta is 0.89, so iBio, Inc.'s price volatility has been lower than the market average.

Beta (5Y) 0.89
52-Week Price Change -59.30%
50-Day Moving Average 0.87
200-Day Moving Average 1.77
Relative Strength Index (RSI) 63.35
Average Volume (20 Days) 6,725,239

Short Selling Information

The latest short interest is 412,382, so 2.04% of the outstanding shares have been sold short.

Short Interest 412,382
Short Previous Month 903,899
Short % of Shares Out 2.04%
Short % of Float 2.15%
Short Ratio (days to cover) 1.23

Income Statement

In the last 12 months, iBio, Inc. had revenue of $400,000 and -$18.38 million in losses. Loss per share was -$1.75.

Revenue400,000
Gross Profit 400,000
Operating Income -18.60M
Pretax Income -18.38M
Net Income -18.38M
EBITDA -17.83M
EBIT -18.60M
Loss Per Share -$1.75
Full Income Statement

Balance Sheet

The company has $8.58 million in cash and $3.57 million in debt, giving a net cash position of $5.01 million or $0.25 per share.

Cash & Cash Equivalents 8.58M
Total Debt 3.57M
Net Cash 5.01M
Net Cash Per Share $0.25
Equity (Book Value) 14.88M
Book Value Per Share 0.77
Working Capital 3.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.30 million and capital expenditures -$16,000, giving a free cash flow of -$15.32 million.

Operating Cash Flow -15.30M
Capital Expenditures -16,000
Free Cash Flow -15.32M
FCF Per Share -$0.76
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -4,650.50%
Pretax Margin -4,594.25%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

iBio, Inc. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -174.05%
Shareholder Yield -174.05%
Earnings Yield -74.98%
FCF Yield -62.51%

Analyst Forecast

The average price target for iBio, Inc. is $4.50, which is 281.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.50
Price Target Difference 281.36%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 29, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date Nov 29, 2023
Split Type Reverse
Split Ratio 1:20

Scores

iBio, Inc. has an Altman Z-Score of -20.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -20.85
Piotroski F-Score 2